Skip to content

    MARAVAI LIFESCIENCES HOLDINGS (MRVI) stock price & financials

    View MRVI earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+229.6% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $69.03M
    $56.56M
    $46.85M
    $47.40M
    $41.63M
    -39.7%
    $49.87M
    -11.8%
    $65.84M
    +40.5%
    $51.44M
    +8.5%
    Strengthening
    Operating Profit
    -$165.61M
    -$37.70M
    -$49.16M
    -$66.28M
    -$41.03M
    +75.2%
    -$58.80M
    -55.9%
    -$2.16M
    +95.6%
    -$15.09M
    +77.2%
    Strengthening
    Net Profit
    -$97.07M
    -$25.91M
    -$29.95M
    -$39.59M
    -$25.56M
    +73.7%
    -$35.68M
    -37.7%
    -$3.73M
    +87.5%
    -$12.42M
    +68.6%
    Strengthening
    EPS
    $-0.68
    $-0.21
    $-0.27
    $-0.18
    +73.5%
    $-0.02
    +90.5%
    $-0.08
    +70.4%
    Strengthening
    Other Income
    Interest
    $13.63M
    $11.26M
    $6.78M
    $6.82M
    $6.84M
    -49.8%
    $6.55M
    -41.8%
    $5.75M
    -15.2%
    $4.81M
    -29.4%
    Weakening
    Depreciation
    Profit before Tax
    -$172.14M
    -$46.07M
    -$52.69M
    -$74.13M
    -$45.15M
    +73.8%
    -$63.01M
    -36.8%
    -$6.53M
    +87.6%
    -$21.80M
    +70.6%
    Strengthening
    MarginsOPM
    -239.9%
    -66.7%
    -104.9%
    -139.8%
    -98.6%
    +58.9%
    -117.9%
    -76.9%
    -3.3%
    +96.9%
    -29.3%
    +79.0%
    Strengthening
    Tax
    -0.2%
    0.0%
    -0.3%
    5.8%
    0.2%
    -0.0%
    -150.0%
    2.3%
    0.8%
    -86.5%
    Weakening
    ReturnsROIC
    1609.6%
    429.5%
    496.5%
    656.5%
    423.7%
    -73.7%
    591.6%
    +37.7%
    61.9%
    -87.5%
    205.9%
    -68.6%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$24.70M$236.18M$551.27M$632.14M$574.96M$322.40M$216.89M$70.09M
    Short-Term Investments
    Total Current Assets$331.60M$740.04M$847.90M$699.91M$429.15M$296.25M$155.66M
    Net PP&E$101.31M$95.43M$116.59M$222.65M$217.03M$190.74M$142.41M
    Goodwill$224.28M$152.77M$283.67M$326.03M$159.88M$129.43M$129.43M
    Intangibles$177.66M$117.57M$216.66M$220.99M$194.96M$151.54M$138.38M
    Total Assets$1.27B$1.92B$2.28B$1.49B$1.01B$770.58M$603.75M
    LiabilitiesTotal Current Liabilities$130.78M$93.78M$110.14M$87.47M$56.97M$44.92M$38.42M
    Short-Term Debt$6.00M$6.00M$5.44M$5.44M$5.44M$5.44M$1.13M
    Long-Term Debt$528.61M$524.59M$522.00M$518.71M$290.49M$286.33M$145.98M
    Long-Term Leases$40.91M$51.56M$47.51M$41.38M$34.03M
    Total Liabilities$1.12B$1.37B$1.38B$697.57M$431.04M$397.87M$248.16M
    EquityCommon Stock & APIC
    Retained Earnings$854.0K$184.56M$404.77M$285.74M$140.89M$10.12M-$6.03M
    Total Equity$144.63M$88.51M$315.50M$545.22M$416.75M$325.29M$212.38M$204.62M
    HighlightsNet Cash / (Debt)-$298.43M$20.68M$104.70M$50.81M$26.47M-$74.88M-$77.01M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$24.11M$152.19M$368.57M$535.98M$126.22M$7.46M-$57.57M-$25.26M
    Cash from Investing-$17.15M$6.07M$105.66M-$267.61M-$122.31M-$24.32M-$31.41M-$9.85M
    Cash from Financing-$4.17M$53.21M-$159.05M-$187.50M-$61.09M-$235.71M-$16.50M-$164.27M
    SummaryCapital Expenditure-$17.15M-$25.41M-$14.85M-$17.09M-$65.55M-$29.66M-$13.15M-$10.58M
    Free Cash Flow$6.97M$126.78M$353.72M$518.89M$60.67M-$22.19M-$70.72M-$35.84M
    FCF Margin4.9%44.6%44.3%58.8%21.0%-8.6%-38.1%-17.2%

    Ratios